Key result
Dopamine induces dose-dependent renal vasodilation via D1 receptors competitively blocked by butaclamol, haloperidol, and sulpiride.
Why the study?
The renal vascular dopamine receptors have not been fully characterized pharmacologically in an isolated rat kidney model.
Does dopamine induce renal vasodilation in isolated rat kidneys, and what type of receptors mediate this effect?
Does dopamine induce renal vasodilation in isolated rat kidneys, and what type of receptors mediate this effect?
Dopamine induces dose-dependent renal vasodilation in isolated rat kidneys mediated by D1-type receptors.
Answers are grounded in this paper and cite their sources.
Does not support changes in clinical dopamine use; extends D1 mediation evidence to isolated rat kidneys.
We present an in vitro method for studying the renal effects of dopamine in the isolated rat kidney. The organ is perfused in an open circuit and can be maintained satisfactorily for up to 180 min. The responses to dopamine were studied in the presence of phenoxybenzamine (10(-5) M) and sotalol (10(-5) M) while stable renal vasoconstriction was maintained by perfusion with prostaglandine F2 alpha. Dopamine induced dose-dependent renal vasodilation with an ED50 of 2.53 X 10(-6) moles/liter, which was not modified by reserpine pretreatment. (+) Butaclamol but not (-) butaclamol shifted the dopamine dose-response curve to the right in a parallel fashion, indicating competitive antagonism. Haloperidol and sulpiride at concentrations without intrinsic effect on vascular resistance also acted as competitive inhibitors for dopamine. Calculation of empirical pA2 values yielded the following relative potencies for these antagonists: (+) butaclamol greater than haloperidol greater than sulpiride. The renal vascular dopamine receptors are tentatively classified as being of the D1 type.
No takes yet. Share an insight, caveat, or question.
Schmidt et al. (1980) studied this question. Dopamine vs. Antagonists ((+) butaclamol, haloperidol, sulpiride) was evaluated on Renal vasodilation. Dopamine induced dose-dependent renal vasodilation that was competitively antagonized by (+) butaclamol, haloperidol, and sulpiride, indicating D1 type receptors.
Synapse has enriched 10 related papers. Consider them for comparative context: